Relating to authorizing the Office of Inspector General to promulgate a legislative rule relating to hospital licensure

2025 Regular Session Introduced by Doug Smith

Bill HB 2253 requires hotels and restaurants to stock opioid antagonists like naloxone, enhancing emergency responses to overdoses and saving lives in the community.

To House Health and Human Resources

#legislature--rulemaking

Introduction

Bill HB 2253 was introduced on January 22, 2024, and is currently under consideration in the legislative process. The bill addresses various health-related issues, particularly focusing on the administration of opioid antagonists and their availability in specific settings such as hotels and restaurants.

Purpose and Intent

The primary purpose of HB 2253 is to enhance public health measures related to the opioid crisis by ensuring that opioid antagonists, such as naloxone, are more readily available in community settings. This initiative aims to reduce opioid overdose deaths and improve the response to opioid-related emergencies.

Key Provisions

Opioid Antagonist Availability: The bill mandates that hotels and restaurants have opioid antagonists on hand to assist in emergency situations involving opioid overdoses.

Training Requirements: It may include provisions for training law enforcement officers and staff in these establishments on how to administer opioid antagonists effectively.

Funding and Administration: The bill outlines the role of the Department of Health (DOH) in overseeing the implementation of these measures, including potential funding mechanisms through county funds.

Affected Parties

Hotels and Restaurants: These establishments will be required to stock opioid antagonists and ensure staff are trained in their use.

Law Enforcement Officers: Officers may receive additional training to respond to opioid-related emergencies more effectively.

General Public: The broader community will benefit from increased access to life-saving medications in public spaces.

Legislative Timeline and Actions

January 22, 2024: Bill introduced and passed its first reading.

February 2024: The bill underwent several committee reviews and amendments, with recommendations for passage.

April 2024: The bill was re-referred to multiple committees and received notice of disagreement regarding Senate amendments. House conferees were appointed to resolve differences.

Current Status: As of April 18, 2024, the bill is in the conference stage, where House and Senate members will negotiate the final provisions.

Conclusion

HB 2253 represents a proactive approach to addressing the opioid crisis by increasing the availability of opioid antagonists in public settings. Its successful passage could lead to significant improvements in emergency response to opioid overdoses, ultimately saving lives and enhancing community health. The ongoing legislative discussions will determine the final form of the bill and its implementation timeline.

Bill